Exclusive: When UnitedHealth came to town

UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice

August 28, 2024 Check out STAT+

Sponsored By

STAT+ | UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice Health Care's Colossus: The human cost of a corporate strategy that leverages physicians to maximize profits By Lizzy Lawrence, Casey Ross, Bob Herman, and Tara Bannow NIH launches $270 million anti-overdose research program for, and led by, Native Americans The National Collective Research Effort to Enhance Wellness (N-CREW) is the largest effort to target drug overdoses in native communities. By Lev Facher STAT+ | Neurocrine reports mixed results on schizophrenia therapy in mid-stage trial The compay said the lowest dose of its pill reduced psychosis but higher doses of the drug also tested were ineffective. By Adam Feuerstein Adobe Eli Lilly's lauded discount of its obesity drug Zepbound comes with caveats A deeper look at the announcement suggests the new offering may not expand access as much as the company indicates. By Elaine Chen Hims takes a blow from Lilly's vial news Today's biotech news includes Medicare's new coverage pathway, Hims & Hers reaction to Zepbound, and a Pfizer partnership with Flagship. By Elaine Chen Opinion: Medicare's new transitional coverage of emerging technologies program doesn't go far enough TCET is built on the existing CED chassis and can be deployed only through Medicare's national coverage authority, limiting its impact. By Peter J. Neumann, Elliott Crummer, Anna Kaltenboeck, and Sean R. Tunis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser